Quantcast

Latest Clinical research Stories

2014-08-28 12:29:56

PITTSBURGH, Aug. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration (FDA). This product is the generic version of Teva's Copaxone® 40 mg/mL, which is indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS)....

2014-08-28 12:29:50

Ribbon-Cutting Ceremony Scheduled for September 3, 2014 ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, will hold a ribbon-cutting ceremony on September 3, 2014, in Tasly's corporate offices in Rockville, MD. The ceremony will mark the official launch of Tasly Pharmaceuticals, Inc. as the North American headquarters of Tasly Holding Group, a global technology company established in China...

2014-08-28 08:27:37

-- Fujifilm's pAVEway(TM) Platform Demonstrated >25-fold Improvement in SYN-004 Expression Titers -- ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced today confirmation of exceptional results from the initial phase of cGMP manufacturing of...

2014-08-27 23:14:58

The research team at Avail Clinical is conducting new clinical studies in DeLand, FL. People who are living with fibromyalgia may qualify to participate if they are at least 18 years of age. DeLand, FL (PRWEB) August 27, 2014 *Anyone who is interested in learning more about the clinical trials being conducted in DeLand, FL can visit Avail Clinical Research on the web (http://www.availclinical.com) or contact them directly at (386) 785-2404. Fibromyalgia Over 5 million Americans are...

2014-08-27 23:14:55

The research team at Achieve Clinical is conducting a new clinical study in Birmingham, AL. People who are living with fibromyalgia may qualify to participate if they are at least 18 years of age. Birmingham, AL (PRWEB) August 27, 2014 *To find out more about this fibromyalgia clinical trial in Birmingham, AL, visit Achieve Clinical Research on the web (http://www.achieveclinical.com) or contact them directly at (205) 380-6434. For those who qualify: There is no cost to participate...

2014-08-27 23:07:36

Radiant Sage LLC, a provider of on-demand clinical trial imaging infrastructure solutions, today announced that it has been named to CIOReview’s list of 100 Most Promising Technology Companies. The CIOReview100 includes companies that are gaining momentum in the technology industry and making an impact. Belmont, Mass. (PRWEB) August 27, 2014 “We are honored to be named to this list of top technology vendors,” said Ven Thangaraj, CEO of Radiant Sage. “We are offering truly...

2014-08-27 12:30:03

LYNDHURST N.J. and NINGBO, China, Aug. 27, 2014 /PRNewswire/ -- Amerigen Pharmaceuticals Limited ("Amerigen") and the Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market. Under the terms of the agreement, Amerigen and Menovo will jointly develop products for Amerigen to commercialize in the United States. Menovo will be...

2014-08-27 08:27:21

REDWOOD CITY, Calif., Aug. 27, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will be participating at the FBR Healthcare One on One Conference and presenting at the Morgan Stanley Global Healthcare Conference. Details of the two events are as follows: FBR Healthcare One...

2014-08-26 23:14:00

Under the guidance of QSIT expert Julie Larsen, Principal/Director, Inspection Readiness Services at BioTeknica, attendees will share best practices on how industry uses of this inspection tool. Participants will break into groups where they will examine challenging scenarios and relate them to how they and their companies manage inspections. Falls Church, VA (PRWEB) August 26, 2014 QSIT Secrets to Assure Clean Inspections: A Hands-On Seminar for FDA-Regulated Companies Pre-Conference...

2014-08-26 23:04:51

Journal of Clinical Trial Results to Share Rare, Successful and Non-Successful Trial Results Philadelphia, PA (PRWEB) August 26, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced that its President and CEO, Jeffrey S. Litwin, M.D. has been named editor-in-chief of MultiMedia LLC’s new peer-reviewed publication: Journal of Clinical Trial Results. The online, open-access publication serves researchers,...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'